NYSE:VTR - Ventas Stock Price, Forecast & News

Ventas trades on the New York Stock Exchange (NYSE) under the ticker symbol "VTR."

Ventas announced a quarterly dividend on Tuesday, December 10th. Shareholders of record on Thursday, January 2nd will be given a dividend of $0.7925 per share on Monday, January 13th. This represents a $3.17 dividend on an annualized basis and a dividend yield of 5.36%. The ex-dividend date of this dividend is Tuesday, December 31st. View Ventas' Dividend History.

Ventas, Inc. (NYSE:VTR) posted its quarterly earnings data on Friday, October, 25th. The real estate investment trust reported $0.23 EPS for the quarter, missing analysts' consensus estimates of $0.94 by $0.71. The real estate investment trust earned $983.16 million during the quarter, compared to analyst estimates of $935.43 million. Ventas had a net margin of 12.73% and a return on equity of 4.59%. The company's revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.99 earnings per share. View Ventas' Earnings History.

Ventas is scheduled to release their next quarterly earnings announcement on Friday, April 24th 2020. View Earnings Estimates for Ventas.

Ventas issued an update on its FY 2020 Pre-Market earnings guidance on Thursday, February, 20th. The company provided earnings per share guidance of 3.56-3.69 for the period.

17 brokers have issued 12 month price objectives for Ventas' stock. Their forecasts range from $50.00 to $74.00. On average, they anticipate Ventas' share price to reach $64.78 in the next twelve months. This suggests a possible upside of 9.5% from the stock's current price. View Analyst Price Targets for Ventas.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ventas in the last year. There are currently 3 sell ratings, 12 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Ventas.

Media coverage about VTR stock has been trending negative on Thursday, InfoTrie reports. The research firm identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Ventas earned a coverage optimism score of -2.1 on InfoTrie's scale. They also gave media coverage about the real estate investment trust a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Ventas.

Ventas saw a increase in short interest in January. As of January 15th, there was short interest totalling 6,440,000 shares, an increase of 13.4% from the December 31st total of 5,680,000 shares. Based on an average daily volume of 2,290,000 shares, the short-interest ratio is currently 2.8 days. Approximately 1.7% of the shares of the company are sold short. View Ventas' Current Options Chain.

Some companies that are related to Ventas include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), HCP (HCP), Extra Space Storage (EXR), Medical Properties Trust (MPW), Host Hotels and Resorts (HST), Omega Healthcare Investors (OHI), CubeSmart (CUBE), Life Storage (LSI), EPR Properties (EPR), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP) and Sabra Health Care REIT (SBRA).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ventas investors own include AT&T (T), Verizon Communications (VZ), AbbVie (ABBV), The Coca-Cola (KO), Realty Income (O), Altria Group (MO), Johnson & Johnson (JNJ), Enterprise Products Partners (EPD), Exxon Mobil (XOM) and Pfizer (PFE).

Ventas' stock is owned by a number of of retail and institutional investors. Top institutional shareholders include State Street Corp (6.69%), FMR LLC (3.54%), Bank of New York Mellon Corp (1.90%), Capital International Investors (1.72%), Charles Schwab Investment Management Inc. (1.31%) and Renaissance Technologies LLC (1.00%). Company insiders that own Ventas stock include Debra A Cafaro, Gregory R Liebbe, James D Shelton, John D Cobb, Melody C Barnes, Robert D Reed, Robert F Probst and T Richard Riney. View Institutional Ownership Trends for Ventas.

VTR stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Goldman Sachs Group Inc., Duff & Phelps Investment Management Co., FMR LLC, Heitman Real Estate Securities LLC, Presima Inc., Standard Life Aberdeen plc and Prudential Financial Inc.. Company insiders that have sold Ventas company stock in the last year include Debra A Cafaro, Gregory R Liebbe, James D Shelton, John D Cobb, Robert D Reed and T Richard Riney. View Insider Buying and Selling for Ventas.

VTR stock was bought by a variety of institutional investors in the last quarter, including Lasalle Investment Management Securities LLC, Bank of New York Mellon Corp, Echo Street Capital Management LLC, Brookfield Public Securities Group LLC, River Road Asset Management LLC, UBS Asset Management Americas Inc., Cubist Systematic Strategies LLC and Toronto Dominion Bank. View Insider Buying and Selling for Ventas.

Shares of VTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of VTR stock can currently be purchased for approximately $59.15.

Ventas has a market capitalization of $22.05 billion and generates $3.75 billion in revenue each year. The real estate investment trust earns $409.46 million in net income (profit) each year or $4.07 on an earnings per share basis. Ventas employs 500 workers across the globe.View Additional Information About Ventas.

The official website for Ventas is http://www.ventasreit.com/.

Ventas' mailing address is 353 N. CLARK STREET SUITE 3300, CHICAGO IL, 60654. The real estate investment trust can be reached via phone at 877-483-6827 or via email at [email protected]